Measurements of proteins are of central importance in biomedical research, and disease-related applications include early detection, causal identification, and treatment monitoring. Sensitive, specific, fast, inexpensive detection of multiple proteins in patient samples is critically important for future public health. The broad, long term goals of this project are to develop ultrasensitive new array devices for accurate measurements of panels of proteins. Recent research has shown that panels of 4 to 10 biomarker proteins, as opposed to the single biomarkers now used, will provide much more reliable cancer detection and monitoring. We will develop and optimize microfluidic arrays for proteins that are accurate, cheap, and can detect multiple proteins at levels 10-100 fold lower than any commercial alternatives. This project targets arrays for small panels of biomarker proteins in serum and tissue, not proteomic biomarker discovery or analysis. In the past funding period, we developed nanoparticle-based strategies for ultrasensitive protein immunoarrays using many thousands of enzyme labels on magnetic particles for electrochemical detection, or dye-nanoparticle labels for electro-optical detection. We utilized prototype sensors and arrays to detect up to four cancer biomarker proteins in the serum of prostate cancer patients with high accuracy. We recently combined nanostructured sensor arrays with microfluidics and off-line protein capture by the multilabel magnetic-antibody particles. This powerful approach greatly decreases interferences and can detect biomarker proteins in serum at levels of 100 fg mL-1 (~3 fM), 10-100 fold below capabilities of commercial assays. Such high sensitivity provides new opportunities for detection of biomarkers with inherently ultralow levels. This renewal project seeks to translate our ultrasensitive protein detection approaches into the realization of widespread clinical, surgical, and research applications. The deliverables are optimized, validated microfluidic array devices for ultrasensitive detection of virtually any small panel of proteins. A high-speed array for detection of cancer cell metastasis (spreading) to lymph nodes during cancer surgery will also be developed. For proof-of-concept, specific devices will be designed to predict the probability of oral cancer from collections of serum samples, and to clearly distinguish between viral (humanpapilloma virus) and non-viral oral cancers. Patient and control samples obtained by our NIDCR/NIH collaborators will be used to establish clinical sensitivity and selectivity of the immunoassay devices. Summarized specific aims are: (1) Optimize microfluidic systems featuring nanostructured sensor chips and multilabel amperometry for an 8-protein oral cancer panel;(2) Design and optimize a simple electro-optical microfluidic array using dye-nanoparticle labels detected by electrochemiluminescence (ECL);(3) Establish clinical sensitivity and selectivity for oral cancer diagnosis for the best array systems;(4) Develop a rapid microfluidic assay for detection of a metastasis biomarker in lymph nodes. 1

Public Health Relevance

This project will develop ultrasensitive devices to detect collections of protein biomarkers in patient serum. It will provide new tools for reliable early diagnosis and monitoring of cancer to facilitate personalized therapy. It will also develop a rapid device to detect the spread (metastasis) of cancer.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
9R01EB014586-06A1
Application #
8238687
Study Section
Enabling Bioanalytical and Imaging Technologies Study Section (EBIT)
Program Officer
Korte, Brenda
Project Start
2011-09-15
Project End
2015-08-31
Budget Start
2011-09-15
Budget End
2012-08-31
Support Year
6
Fiscal Year
2011
Total Cost
$369,296
Indirect Cost
Name
University of Connecticut
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
614209054
City
Storrs-Mansfield
State
CT
Country
United States
Zip Code
06269
Mosa, Islam M; Pattammattel, Ajith; Kadimisetty, Karteek et al. (2017) Ultrathin Graphene-Protein Supercapacitors for Miniaturized Bioelectronics. Adv Energy Mater 7:
Shen, Min; Rusling, James; Dixit, Chandra K (2017) Site-selective orientated immobilization of antibodies and conjugates for immunodiagnostics development. Methods 116:95-111
Tang, C K; Vaze, A; Rusling, J F (2017) Automated 3D-printed unibody immunoarray for chemiluminescence detection of cancer biomarker proteins. Lab Chip 17:484-489
Dixit, Chandra K; Bhakta, Snehasis; Kumar, Ajeet et al. (2016) Fast nucleation for silica nanoparticle synthesis using a sol-gel method. Nanoscale 8:19662-19667
Dixit, Chandra K; Kadimisetty, Karteek; Otieno, Brunah A et al. (2016) Electrochemistry-based approaches to low cost, high sensitivity, automated, multiplexed protein immunoassays for cancer diagnostics. Analyst 141:536-47
Mollahosseini, Mehdi; Karunaratne, Erandika; Gibson, George N et al. (2016) Fullerene-Assisted Photoinduced Charge Transfer of Single-Walled Carbon Nanotubes through a Flavin Helix. J Am Chem Soc 138:5904-15
Otieno, B A; Krause, C E; Rusling, J F (2016) Bioconjugation of Antibodies and Enzyme Labels onto Magnetic Beads. Methods Enzymol 571:135-50
Gu, Bing; Sun, Xuanhao; Papadimitrakopoulos, Fotios et al. (2016) Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere/PVA hydrogel composites. J Control Release 228:170-178
Tang, Chi K; Vaze, Abhay; Shen, Min et al. (2016) High-Throughput Electrochemical Microfluidic Immunoarray for Multiplexed Detection of Cancer Biomarker Proteins. ACS Sens 1:1036-1043
Munge, Bernard S; Stracensky, Thomas; Gamez, Kathleen et al. (2016) Multiplex Immunosensor Arrays for Electrochemical Detection of Cancer Biomarker Proteins. Electroanalysis 28:2644-2658

Showing the most recent 10 out of 56 publications